Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged.

ViiV Healthcare to increase annual supply of long-acting HIV PrEP

The long-acting injectable PrEP option is being rolled out at a record pace in sub-Saharan Africa and lower-income countries. Credit: elenavolf/Shutterstock. ViiV Healthcare has announced

October 8, 2024

Study links heavy mobile phone use to lower sperm count

Swiss study finds higher mobile phone use linked to lower sperm count and concentration in young men, raising concerns about RF-EMF exposure’s impact on male

November 3, 2023

Opinion | ‘If You Want Your Stocking Stuffed on Christmas, Go Ahead’: What We Heard This Week

“If you want your stocking stuffed on Christmas, go ahead.” — Justin Dubin, MD, a urologist in South Florida, reassuring couples after a new study

December 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.